Clinical trial
AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small…
NCT00410904 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00410904 |
|---|---|
| Title | AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung Cancer |
| Official title | Phase 2 Study of AZD2171 (NSC 732208) in Combination With Pemetrexed in Relapsed Non-Small Cell Lung Cancer (NOS: 10029514) |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent Non-small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | cediranib maleate, pemetrexed disodium |
| Enrollment | 60 |
| Start date | Oct 1, 2006 |
| Primary completion | Jul 1, 2013 |
| Completion | Mar 1, 2014 |
| First posted | Dec 13, 2006 |
| Last update posted | Apr 13, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: